Short-term effects of an SGLT2 inhibitor on divalent ions in autosomal dominant polycystic kidney disease: a randomized crossover trial.

Roth L, Harmacek D, Schachtner T, George B, Hofmann C, Georgalis AD, Venzin RM, Hofmann P, Fehr TH

Open source

DOI
10.1093/ckj/sfag349
Published
2026 Oct
Container
Clinical kidney journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ckj/sfag349,
  title = {Short-term effects of an SGLT2 inhibitor on divalent ions in autosomal dominant polycystic kidney disease: a randomized crossover trial.},
  author = {Roth L and Harmacek D and Schachtner T and George B and Hofmann C and Georgalis AD and Venzin RM and Hofmann P and Fehr TH},
  year = {2026},
  journal = {Clinical kidney journal},
  doi = {10.1093/ckj/sfag349},
  url = {https://doi.org/10.1093/ckj/sfag349}
}

RIS

TY  - JOUR
TI  - Short-term effects of an SGLT2 inhibitor on divalent ions in autosomal dominant polycystic kidney disease: a randomized crossover trial.
AU  - Roth L
AU  - Harmacek D
AU  - Schachtner T
AU  - George B
AU  - Hofmann C
AU  - Georgalis AD
AU  - Venzin RM
AU  - Hofmann P
AU  - Fehr TH
PY  - 2026
JO  - Clinical kidney journal
DO  - 10.1093/ckj/sfag349
UR  - https://doi.org/10.1093/ckj/sfag349
ER  - 

APA

L, R., D, H., T, S., B, G., C, H., AD, G., RM, V., P, H., & TH, F. (2026). Short-term effects of an SGLT2 inhibitor on divalent ions in autosomal dominant polycystic kidney disease: a randomized crossover trial.. Clinical kidney journal. https://doi.org/10.1093/ckj/sfag349

Source records